News

Researchers from the University of Leicester are among those hoping to create an improved vaccine to fight tuberculosis as part of a €9 million Euro project.

According to researchers, drugs used to treat rare conditions are earning pharmaceutical companies almost as much as those marketed to the general public.

By silencing the molecular pathway that prevents macrophages from attacking our own cells, scientists have manipulated these white blood cells to eliminate solid tumors.

Some microbes in the guts of humans and mice may help control the buildup of plaque in arteries, the leading cause of cardiovascular disease, by gobbling up a group of inflammatory chemicals before they can circulate in the body.

A stem cell treatment that can be transplanted into an injured heart to repair damaged tissue and improve heart function has shown promise in preclinical trials.

New study suggests some vaccines could induce a protective shift in the microorganisms that live with a host organism.

Public confidence in vaccines has plunged across sub-Saharan Africa since the COVID-19 pandemic, according to a study of 17,000 people, across eight countries.

Research has identified a protein, found in the main vector of the bacterium that causes Brazilian spotted fever, that is essential to the vector's survival, making it a promising target for vaccine development.

A successful long-term experiment with live pigs indicates scientists may be another step closer to achieving a safe, long-lasting and potentially universal vaccine against swine flu.

The ISSCR has released the ISSCR Standards for Human Stem Cell Use in Research, an international collaboration aimed at enhancing rigor in preclinical research and ultimately strengthening the pipeline of therapies for patients.